reference/26066410

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26066410

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	87
issn	1528-9117
issueIdentifier	5
pageRange	377-87
publicationName	Cancer journal (Sudbury, Mass.)
startingPage	377
bibliographicCitation	Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein M, Coleman RE, Reitsma DJ, Seaman JJ, Chen BL, Ambros Y. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J. 2001 Sep;7(5):377–87. PMID: 11693896.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dba6712a5de5a88465c418c147e97f1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d1289f6db7265234382dc702be34efbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8dd08f0d4f0b659537cceaa3b0210c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4b146e4940b18bf6333ddd871ae3cc3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e044eb85bf5a5e17ca37c95a271f0df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40470890d22ecc232a0e2c523a0724ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dd32140c8507bfec8687ab2312304b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f47a0ea6c75111dc292970139f14bbbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9a585505377fe30e66b15dde0389dbf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9451c0258a3309418f03e9f367b80f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70e99e692775441ea7e09ff8f6dd4489 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7956f263c4be69251e978adb12ac193c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4eeadc66c3d1d409c86a0a56639c275e
date	200109
identifier	https://pubmed.ncbi.nlm.nih.gov/11693896
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21896 https://portal.issn.org/resource/ISSN/1528-9117
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial
discusses	http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0011048 http://id.nlm.nih.gov/mesh/M0071565 http://id.nlm.nih.gov/mesh/M0006519
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D009101Q000473 http://id.nlm.nih.gov/mesh/D007093Q000627 http://id.nlm.nih.gov/mesh/D001859Q000556 http://id.nlm.nih.gov/mesh/D001943Q000473 http://id.nlm.nih.gov/mesh/D004164Q000627 http://id.nlm.nih.gov/mesh/D001859Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D015337 http://id.nlm.nih.gov/mesh/D007093Q000009 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000077268 http://id.nlm.nih.gov/mesh/D000077211 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004164Q000009 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D004311
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10923 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4674 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64747 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8729 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7732

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129624957

Total number of triples: 66.